HRT Financial’s Cingulate CING Stock Holding History

HRT Financial’s Portfolio CING Stock Details CING Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-33,144	Closed	-$205K	–	4338
2026 Q1	$205K	Buy	+33,144	New	+$212K	﹤0.01%	3185
2024 Q2	–	Sell	-891	Closed	-$11K	–	2323
2024 Q1	$11K	Buy	+891	New	+$28.6K	﹤0.01%	2057

Other funds holding CING

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAM

BCV Asset Management Winnipeg $3.31B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's CING Position: Q2 2026 in Review

HRT Financial sold out of Cingulate (CING) in Q2 2026, closing a stake of 33,144 shares — an estimated $205K sold.

HRT Financial first reported a position in CING in Q1 2024 and held it in 2 quarters. The position peaked at $205K in Q1 2026. 33 funds tracked by Wall St. Rank hold CING as of Q2 2026.

HRT Financial reported no remaining Cingulate position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 33,144 Cingulate shares in Q2 2026, an estimated $205K.
HRT Financial first reported a position in Cingulate in Q1 2024 and held it in 2 quarters.
HRT Financial's Cingulate position peaked at $205K in Q1 2026.
33 funds tracked by Wall St. Rank held Cingulate as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.